| Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767) |
|---|
| 02/23/2005 | EP1507539A1 Hormone replacement therapy using a combination of conjugated estrogens and trimegestone |
| 02/23/2005 | EP1507535A1 Pyrimidine-2,4,6-trione metallo-proteinase inhibitors |
| 02/23/2005 | EP1507528A2 Methods for using jnk inhibitors for treating or preventing disease-related wasting |
| 02/23/2005 | EP1507514A2 Controlled release compositions of estradiol metabolites |
| 02/23/2005 | EP1317421B1 2-amino-2-alkyl-5 heptenoic and heptynoic acid derivatives useful as nitric oxide synthase inhibitors |
| 02/23/2005 | EP1286986B1 Quinolinyl-piperidin-4-ylidene-methyl-benzamide derivatives for the treatment of pain |
| 02/23/2005 | EP1274710B1 Novel heteroaryl-diazabicycloalkanes |
| 02/23/2005 | EP1133482B1 Il-5 inhibiting 6-azauracil derivatives |
| 02/23/2005 | EP1107962B1 Quinolin-2-one derivatives useful as anticancer agents |
| 02/23/2005 | EP0854709B2 Use of boswellic acid and its derivatives for inhibiting normal and increased leucocytic elastase or plasmin activity |
| 02/23/2005 | CN1585772A Chemokine receptor antagonists and methods of use thereof |
| 02/23/2005 | CN1585771A Polycyclic guanine derivative phosphodiesterase V inhibitors |
| 02/23/2005 | CN1585769A A2b adenosine receptor antagonists |
| 02/23/2005 | CN1585767A Dimeric compounds and their use as anti-viral agents |
| 02/23/2005 | CN1585766A Dimeric compounds and their use as anti-viral agents |
| 02/23/2005 | CN1585763A Piperidine derivatives and their use as modulators of chemokine receptor activity especially CCR5 |
| 02/23/2005 | CN1585755A Benzamide and heteroarylamide as P2X7 receptor antagonists |
| 02/23/2005 | CN1585750A Anthranilic acid amides and their use as VEGF receptor tyrosine kinase inhibitors |
| 02/23/2005 | CN1585749A Cannabinoid receptor ligands |
| 02/23/2005 | CN1585748A NK1 antagonists |
| 02/23/2005 | CN1585747A Azetidinyl diamines useful as ligands of the nociceptin receptor ORL-1 |
| 02/23/2005 | CN1585745A Hydroxyfattysulfonic acid analogs |
| 02/23/2005 | CN1585742A Aryl aniline beta-2 adrenergic receptor agonists |
| 02/23/2005 | CN1585648A Enamel matrix protein compositions for modulating immune response |
| 02/23/2005 | CN1585641A Hydrazono-malonitriles |
| 02/23/2005 | CN1585640A N-adamantylmethyl derivates and intermediates as pharmaceutical compositions and processes for their preparation |
| 02/23/2005 | CN1585638A Linked biaryl compounds |
| 02/23/2005 | CN1585633A Phenethanolamine derivatives for treatment of respiratory diseases |
| 02/23/2005 | CN1583172A Multifunctional liquid for clean therapy of nasal cavity and sinuses |
| 02/23/2005 | CN1583170A Medicine for human lysozyme against virus and drug-fast bacteria and its preparation |
| 02/23/2005 | CN1583167A Use of recommbined human lysozyme in preparation of medicine for bronchial asthma |
| 02/23/2005 | CN1583149A Health care tea for nourishing lung and arresting cough |
| 02/23/2005 | CN1583146A Preparation and preparing method for asthenia diseases of breath and blood circulation systems |
| 02/23/2005 | CN1583130A Frozen dry powder injection of houttuynia cordata and its preparation |
| 02/23/2005 | CN1583115A External used ointment for cough and asthma and its preparation |
| 02/23/2005 | CN1583114A Chinese medicine of atypical pneumonia Ke-3 and its preparation |
| 02/23/2005 | CN1583113A Chinese medicine of atypical pneumonia Ke-1 and its preparation |
| 02/23/2005 | CN1583094A Plant liquor for removing heat from lung to relieve cough |
| 02/23/2005 | CN1583079A Prescription of |
| 02/23/2005 | CN1583046A Saponin capsules |
| 02/23/2005 | CN1583045A Composite glycyrrhizae preparation and its preparing method |
| 02/23/2005 | CN1583042A Yanreqing capsules and their preparation |
| 02/23/2005 | CN1583016A Kebiting preparation for relieving cough and its preparing method |
| 02/23/2005 | CN1583009A Extracts of Chinese medicine for asthma and their preparation and preparing method |
| 02/23/2005 | CN1583001A Infrared cough relieving paste |
| 02/23/2005 | CN1582977A Medicine for clearing away heat and toxic material, relieving cough and asthma and reducing sputum |
| 02/23/2005 | CN1582972A Sugarless Xiasangju granules |
| 02/23/2005 | CN1582954A Composition of roxithromycin and ambroxol |
| 02/23/2005 | CN1582939A Dioxyimipramine hydrochloride drops and their preparation |
| 02/23/2005 | CN1582916A Medicinal composition with sodium houttuy fonate and ambroxol hydrochloride |
| 02/23/2005 | CN1582907A Pseudoephetonin drops and their preparation |
| 02/23/2005 | CN1582905A Use of emodin in preparation of antagonistic TGF beta-1 and medicines to prevent tissues from fibrosis |
| 02/23/2005 | CN1190437C Pteridine compounds for treatment of psoriasis |
| 02/23/2005 | CN1190424C Quinoline-containing Alpha-ketoamide cysteine and serine protease inhibitors |
| 02/23/2005 | CN1190211C Process for preparing cough-relieving medicine |
| 02/22/2005 | US6858740 2-oxo-1-pyrrolidine derivatives, process for preparing them and their uses |
| 02/22/2005 | US6858739 Indole and benzimidazole 15-lipoxygenase inhibitors |
| 02/22/2005 | US6858642 For use in pharmaceutical, skin-protective and cosmetic formulations |
| 02/22/2005 | US6858620 For therapy of male erectile dysfunction; female arousal disorder |
| 02/22/2005 | US6858615 Phenyl guanidine sodium channel blockers |
| 02/22/2005 | US6858614 Such as 4-(4-hydroxyphenyl)butylamidino-3,5-diamino-6-chloropyrazinecarboxamide hydrochloride; time-release agents; for treating chronic bronchitis, emphysema, cystic fibrosis, and eye disorders |
| 02/22/2005 | US6858603 Acetindine derivatives, their preparation and medicaments containing them |
| 02/22/2005 | US6858597 Halogenated sulphamate-, phosphonate-, thiophosphonate-, sulphonate- and sulphonamide- compounds as inhibitors of steroid sulphatase |
| 02/22/2005 | US6858596 Aqueous suspension of Fluticasone furoate; respiratory tract disorders; asthma, COPD; antiinflammatory, antiallergen; nasal inhaler |
| 02/22/2005 | US6858581 Peptides which are modified with at least one hydrocarbyl group and which possess antimicrobial acitivity |
| 02/22/2005 | CA2438055A1 Treatment of allergic rhinitis |
| 02/22/2005 | CA2184581C Improved dnase liquid solutions |
| 02/22/2005 | CA2129039C Tri-substituted phenyl derivatives as phosphodiesterase inhibitors |
| 02/17/2005 | WO2005014611A1 The artificial cpg single strand deoxidation oligonucleotide and its antiviral uses |
| 02/17/2005 | WO2005014580A1 Pyridyl piperazinyl ureas |
| 02/17/2005 | WO2005014576A1 Isoquinolinone derivative, process for producing the same and use thereof |
| 02/17/2005 | WO2005014572A1 Pyrimidylpyrrole derivatives active as kinase inhibitors |
| 02/17/2005 | WO2005014030A1 Method for treating lung diseases associated with ventilation-perfusion mismatches |
| 02/17/2005 | WO2005014005A1 Combination of an anticholinergic and a steroid and its use to treat respiratory disorders by inhalation |
| 02/17/2005 | WO2005013999A1 Medicaments for inhalation comprising steroids and a novel anticholinergic |
| 02/17/2005 | WO2005013995A1 4-substituted 7-alkoxy-2-aminosulfonyl-1,2-dihydro-phtalazin derivatives as phosphodiesterase 4 inhibitors for the treatment of allergies and inflammations |
| 02/17/2005 | WO2005013994A1 Medicaments for inhalation comprising anticholinergics and a betamimetic |
| 02/17/2005 | WO2005013993A1 Medicaments comprising pde iv inhibitors and an anticholinergic for treating respiratory disorders |
| 02/17/2005 | WO2005013992A1 Medicaments for inhalation comprising betamimetics and an anticholinergic agent |
| 02/17/2005 | WO2005013986A1 Pyridylpyrrole derivatives active as kinase inhibitors |
| 02/17/2005 | WO2005013967A1 Medicaments comprising pde iv inhibitors and a novel anticholinergic and their use for treating respiratory disorders |
| 02/17/2005 | WO2005013966A1 Macrophage activation inhibitor |
| 02/17/2005 | WO2005013965A1 Use of cis-99, trans-11 isomer of conjugated linoleic acid (cla) for treating inflammatory diseases |
| 02/17/2005 | WO2005013963A1 Advantageous combinations for inhalation of nacystelyn and bronchodilators |
| 02/17/2005 | WO2005013691A1 Use of boranocarbonates for the therapeutic delivery of carbon monoxide |
| 02/17/2005 | WO2004110344A3 New azetidine compounds |
| 02/17/2005 | WO2004103407A3 Composition comprising a pde4 inhibitor and a pde5 inhibitor |
| 02/17/2005 | WO2004087200B1 Vaccine and serum for protection of cystic fibrosis patients against pseudomonas aeruginosa |
| 02/17/2005 | WO2004070050A3 Cyclic urea derivatives, preparation method thereof and pharmaceutical use of same as kinase inhibitors |
| 02/17/2005 | WO2004016578A8 Arylethanolamine beta2-adrenoreceptor agonist compounds |
| 02/17/2005 | WO2003099192A8 Bis-aromatic alkanols |
| 02/17/2005 | WO2003080568A3 Probucol derivatives |
| 02/17/2005 | WO2002074913A3 Nucleic acid-associated proteins |
| 02/17/2005 | US20050038259 Elastase release inhibitors; such as 19-(1H-tetrazol-5-yl)nonadec-6-en-5-ol |
| 02/17/2005 | US20050038243 2, 4-pyrimidinediamine compounds and their uses |
| 02/17/2005 | US20050038119 for treatment of neutrofil-dependent pathologies such as psoriasis, ulcerative colitis, melanoma, chronic obstructive pulmonary disease (COPD), bollous pemphigo, rheumatoid arthritis, idiopathic fibrosis, glomerulonephritis; prevention and treatment of damages caused by ischemia and reperfusion |
| 02/17/2005 | US20050038118 Treatment |
| 02/17/2005 | US20050038072 Nitrogeneous cyclic ketone derivative, process for producing the same, and use |
| 02/17/2005 | US20050038069 Tumor necrosis factor antagonist; antiinflammatory agents; such as 2-Cyclopropyl-4-(3,5-dimethyl-4-pyridylmethoxy)-7-methoxy-3H-benzimidazole |
| 02/17/2005 | US20050038061 6-Aminomorphinane derivatives, method for production and use thereof |